Clevidipine
Clevidipine (INN, trade name Cleviprex) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable. It was approved by the United States Food and Drug Administration on August 1, 2008.
primaryTopic
Clevidipine
Clevidipine (INN, trade name Cleviprex) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable. It was approved by the United States Food and Drug Administration on August 1, 2008.
has abstract
Clevidipin (Handelsname Clevip ...... der Schweiz 2010. zugelassen.
@de
Clevidipine (INN, trade name C ...... inistration on August 1, 2008.
@en
Klewidypina (łac. clevidipinum ...... ującym kanały wapniowe typu L.
@pl
ATC prefix
ATC suffix
Bioavailability
CAS number
167221-71-8
FDA UNII code
19O2GP3B7Q
IUPAC name
O3-(butanoyloxymethyl) O5-meth ...... ydropyridine-3,5-dicarboxylate
@en
PubChem
thumbnail
Link from a Wikipage to an external page
Wikipage page ID
17,343,462
Wikipage revision ID
741,801,611
ChEMBL
ChemSpiderID
elimination half-life
excretion
urine 63-74%, feces 7-22%
legal US
licence US
metabolism
blood and tissue esterases
molecular weight
4.56316e+2
protein bound
routes of administration
smiles
tradename
hypernym
comment
Clevidipin (Handelsname Clevip ...... der Schweiz 2010. zugelassen.
@de
Clevidipine (INN, trade name C ...... inistration on August 1, 2008.
@en
Klewidypina (łac. clevidipinum ...... ującym kanały wapniowe typu L.
@pl
label
Clevidipin
@de
Clevidipine
@en
Klewidypina
@pl
